Skip to content

Welcome to Discover Pharma! Today is : October 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Precision Medicine

  • Clinical & Regulatory,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Mursla Bio validates liver-specific liquid biopsy platform

    Mursla Bio has published peer-reviewed data showing that isolating liver-derived [...]

    October 13, 2026
  • Advanced Therapies,Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Laverock Therapeutics expands into in vivo CAR-T and genetic medicine

    Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

    September 30, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Manufacturing & Supply Chain,Research & Development

    Saudi Arabia announces biotech deals and research partnerships worth SAR 5.5BN

    Saudi Arabia has announced more than SAR 5 billion in [...]

    September 18, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Big Picture Bio launches with £2.2M to design cancer drug combinations

    Big Picture Bio has launched with £2.2 million in funding [...]

    September 18, 2026
  • Biotech & Pharma Business,Digital & Data,Research & Development

    Lifebit awarded three-year NIHR BioResource research environment contract

    Lifebit has been awarded a three-year contract by the University [...]

    September 16, 2026
  • Advanced Therapies,Central Nervous System,Genomics and sequencing,Research & Development

    Researchers develop electromagnetic gene switch for remote control of gene expression

    Researchers at Dongguk University in South Korea have developed an [...]

    August 17, 2026
  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    Tagomics launches cfDNA platform for multi-organ drug safety monitoring

    Tagomics has launched a cell-free DNA platform designed to monitor [...]

    August 17, 2026
  • Biotech & Pharma Business,Digital & Data,Genomics and sequencing,Research & Development,Therapeutic Areas

    Bios Life launches with $25M funding and Tempus cancer AI partnership

    Bios Life has emerged from stealth with $25M in seed [...]

    August 12, 2026
  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    NEB launches cell-free RNA extraction kit for liquid biopsy research Slug: neb-c

    New England Biolabs has launched a magnetic bead-based extraction kit [...]

    August 5, 2026
  • Digital & Data,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    AI model cuts radiopharmaceutical dose mapping to seconds in prostate cancer study

    A new AI model has generated patient-specific radiation dose-rate maps [...]

    August 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • BridgeBio gets FDA Priority Review for oral infigratinib in achondroplasia
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Shift Bioscience publishes AI virtual cell framework for target discovery
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top